SETD1A has been found to promote tumors’ progression in various cancers, such as lung cancer, breast cancer, gastric cancer, colorectal cancer, and leukemia, by regulating TGF-β, Wnt, and Hippo/YAP signaling pathways (42). Here, SETD1A is linked to leukemia.